Applied therapeutics added to russell 3000® index

New york, july 01, 2024 (globe newswire) -- applied therapeutics, inc. (nasdaq: aplt), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the company was added to the russell 3000® index, effective after the u.s. market closed on june 28, 2024, as part of the 2024 russell indexes annual reconstitution.
APLT Ratings Summary
APLT Quant Ranking